Tong Gao

Dr. Tong Gao

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JLJinhu Liu
Jinhu Liu
WMWeiwei Mu
Weiwei Mu
TGTong Gao
Tong Gao
YFYuxiao Fang
Yuxiao Fang
NZNa Zhang
Na Zhang
YLYongjun Liu
Yongjun Liu
Liver cancer, especially hepatocellular carcinoma, is an important cause of cancer-related death, and its incidence is increasing worldwide. Nano drug delivery systems have shown great promise in the treatment of cancers. In order to improve their therapeutic efficacy, it is very important to realize the high accumulation and effective release of drugs at the tumor site. In this manuscript, using doxorubicin (DOX) as a model drug, CD13-targeted mesoporous silica nanoparticles coated with NGR-peptide-modified pegylated carboxymethyl chitosan were constructed (DOX/MSN-CPN). DOX/MSN-CPN comprises a spherical shape with an obvious capping structure and a particle size of 125.01 ± 1.52 nm. With a decrease in pH, DOX/MSN-CPN showed responsive desorption from DOX/MSN-CPN and pH-responsive release of DOX was observed. Meanwhile, DOX/MSN-CPN could be efficiently absorbed through NGR-mediated internalization in vitro and could efficiently deliver DOX to tumor tissues with long accumulation times in vivo, suggesting good active targeting properties. Moreover, significant tumor inhibition has been observed in antitumor studies in vivo. This study provides a strategy of utilizing DOX/MSN-CPN as a nano-platform for drug delivery, which has superb therapeutic efficacy and safety for the treatment of hepatocellular carcinoma both in vivo and in vitro.

20 November 2025 in Journal of Controlled Release
Verified
Journal Article
Closed access
YSYing Sun
Ying Sun
JSJialin Sun
Jialin Sun
QGQie Guo
Qie Guo
YLYan Liu
Yan Liu
ZZZipeng Zhang
Zipeng Zhang
TGTong Gao
Tong Gao